BackPurple Biotech Overview

Purple Biotech Long Term Debt

Purple Biotech's long-term debt is $0.

Get informed when a big investor buys or sells

+ Follow
Long Term Debt
$0.00

Peer average

Loading

Purple Biotech Long Term Debt History

Loading

Purple Biotech vs. peers: Long Term Debt Comparison

Loading

Purple Biotech Long Term Debt Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Purple Biotech (PPBT) FAQ

As of the most recent data (March 2026), PPBT shows a long-term debt of $0. In the prior-year period, the figure was $0. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, PPBT's long-term debt is now $0 (was $0). Pairing that YoY change with peer averages gives a clearer picture of whether Purple Biotech is outperforming or lagging.

Tracking PPBT's long-term debt over time shows whether Purple Biotech is scaling, shrinking, or reshaping that part of the business. The current reading is $0 In the prior-year period, the figure was $0. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this long-term debt page, Stockcircle has Purple Biotech's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect long-term debt (currently $0) with ownership activity and broader fundamentals.

Purple Biotech's long-term debt is $0; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.